September 12, 2025 - 20:35

In a recent private meeting, the interim CEO and director of Kenvue, the company behind the popular pain reliever Tylenol, engaged in discussions with U.S. Health and Human Services Secretary Robert F. Kennedy Jr. The meeting aimed to address concerns regarding the potential association between the medication and autism. The CEO emphasized that scientific research has not established any clear link between the use of Tylenol and the development of autism spectrum disorders.
The dialogue comes amidst rising scrutiny and ongoing debates surrounding the safety of various medications during pregnancy and early childhood. The CEO's efforts appear to be focused on preventing the inclusion of Tylenol in a forthcoming report that could suggest a connection to autism, a point of contention that has garnered significant public interest and concern.
Both parties acknowledged the importance of continuing to review and analyze existing research to ensure public safety while addressing the anxieties of parents and caregivers.
November 20, 2025 - 01:54
Function Health Secures $300 Million Investment to Expand Consumer Lab Testing ServicesFunction Health, a pioneering startup in the wellness sector, has successfully raised $300 million to enhance its offerings of lab tests and scans directly to consumers. This significant funding...
November 19, 2025 - 06:46
Solicitors Reach Out to Health Secretary Regarding Addenbrooke's Surgical ErrorsSolicitors representing over 50 former patients of surgeon Kuldeep Stohr have formally contacted Health Secretary Wes Streeting to address concerns over a series of botched operations at...
November 18, 2025 - 18:48
NYC Health + Hospitals/Queens Achieves Top Safety Rating for Fall 2025NYC Health + Hospitals/Queens has proudly announced that it has earned an `A` Hospital Safety Grade for Fall 2025 from The Leapfrog Group. This accolade marks a continuation of the hospital`s...
November 18, 2025 - 01:37
Navigating Health Insurance at Age 26 in MinnesotaAs individuals approach their 26th birthday, they often face a significant change in their health insurance options. Once they reach this milestone, they typically become ineligible to remain on a...